A detailed history of Northwest Investment Counselors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Northwest Investment Counselors, LLC holds 20 shares of MRNA stock, worth $787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Holding current value
$787
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$63.64 - $125.14 $1,272 - $2,502
20 New
20 $1,000
Q1 2024

Apr 12, 2024

BUY
$85.37 - $115.44 $1,707 - $2,308
20 New
20 $2,000
Q3 2023

Oct 12, 2023

SELL
$96.41 - $126.61 $771 - $1,012
-8 Reduced 15.09%
45 $4,000
Q2 2023

Jul 11, 2023

BUY
$118.5 - $160.53 $948 - $1,284
8 Added 17.78%
53 $6,000
Q4 2022

Jan 18, 2023

BUY
$118.38 - $210.04 $2,367 - $4,200
20 Added 80.0%
45 $0
Q3 2022

Oct 28, 2022

BUY
$118.07 - $194.18 $2,951 - $4,854
25 New
25 $3,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.